Responsibilities
- Developing and leading the Enterprise Programs team within the PD department
- Managing tech transfer and process development activities to enable regulatory filing
- Serving as the company’s internal subject matter expert with regards to cell therapy manufacturing questions associated with all Enterprise Programs
- Assuming responsibility for tracking and planning resource allocation, budgets, headcount and continuous team, process and technology improvements
- Developing best practices, templates, and standards for transitioning processes from development into characterization and, ultimately, manufacturing
- Planning the process development team’s work for the quarters to come with clearly defined goals and resourcing plans
- Performing gap analyses and translating existing manual and/or automated processes onto the Cell Shuttle platform
- Performing and supporting in the execution of verification, validation, and performance qualification
- Authoring standard operating procedures, protocols, and batch records for the manufacturing of Enterprise Program cell therapies
- Working with our Analytical Development team to assess and quantify the quality of cell therapy manufacturing process steps in meeting Enterprise Program client requirements
- Authoring high-quality regulatory submissions and technical reports; independently prepare and present data/findings at department, project team, and senior management meetings
Requirements
- PhD, M.S. or B.S. in biological sciences (Molecular Biology, Immunology, Genetics)
- Excellent organizational and communications skills and strong ability to lead and work with individuals across all levels in the organization
- 4+ years of experience in the cell and gene therapy manufacturing or process development space, with at least two years in an industry setting.
- Extensive experience with different modalities of genetically modified cell therapies (e.g. CAR-T, TCR, HSCs, CD34+)
- Experience with both autologous and allogeneic cell therapy manufacturing workflows in preclinical, clinical and/or commercial environments
- Experience representing companies externally, with strong client relationship management skills
- Experience with managing and growing process development teams and processes
- Strong experimental design and troubleshooting skills, able to distill complex scientific information into simple and actionable final reports
- Experience working in a GMP environment and familiarity with quality requirements
- Demonstrated experience in process optimization, characterization and tech transfer
- Excellent data analysis skills and experience with a variety of scientific software applications
- Great verbal and written communication skills and the ability to interpret, summarize, and present scientific results in a clear, concise, accurate manner to both technical and non-technical audiences
- Must be able to travel up to 15% of the time
- Self-awareness, integrity, authenticity and a growth mindset
Nice to haves
- Experience interfacing with the FDA
- PhD / post-doctoral experience in the gene/cell therapy field
- Experience authoring CMC sections for IND, IMPD and NDA
- Proven track record of utilizing management and process improvement tools (daily management, problem solving & root cause analysis tools, value stream mapping etc.) to meet and exceed strategic business objectives
Top Skills
What We Do
Cellares is revolutionizing cell therapy manufacturing. We are developing a one-of-a-kind solution, The Cell Shuttle, to overcome the challenges associated with manufacturing so these life-saving therapies are affordable and widely available to patients who can benefit.
The clinical impact of cell therapy in treating cancer has been proven, but this therapeutic approach has several limitations, especially in manufacturing, leaving extremely sick patients waiting for treatment and desperate for hope.
Since cell therapy is currently produced for a single patient at a time, it is expensive to manufacture, requiring significant time and resources, and is difficult to scale.
Preclinical and clinical scientists, as well as commercial cell therapy manufacturers also lack the options to fully automate their manufacturing process quickly, safely, cost-effectively and at the scale they need.
The Cell Shuttle is an automated and closed end-to-end manufacturing solution that is flexible and scalable, enabling customers to run exact processes specified for their cell therapy. Compared with the current manual manufacturing processes for cell therapy, the Cell Shuttle’s next-generation automated manufacturing solution has 10 times the scalability (meaning 10 times more patient doses can be produced simultaneously), enables a three-fold reduction in process failure rates and will reduce the per-patient manufacturing cost by up to 70 percent for most processes.